Tag Archives: Bristol Myers Squibb

Bristol-Myers Squibb Sells Diabetes Business to AstraZeneca

Bristol-Myers Squibb has agreed to sell its global diabetes business that was part of its collaboration with AstraZeneca for $2.7 billion with potential regulatory- and sales-based milestone payments of up to $1.4 billion and will make royalty payments based on net sales through 2025. In addition, AstraZeneca will make payments of up to $225 million […]
Posted in Deals, Guest Blog | Also tagged , , | Leave a comment

HIV Market Banking on Fixed-Dose Treatments

The HIV markets are expected to grow for the next two years, but major patent expirations in the following years will have a huge impact on pharmaceutical sales by 2019, according to a new report by DataMonitor. Antiretroviral sales in 2009 were estimated at $11.8 billion. While that figure is forecast to hit $14.4 billion […]
Posted in R&D | Also tagged , , , , , , | Leave a comment

Patient Adherence Awards Winners Revealed

Image via Wikipedia The Center for Business Intelligence, on Monday, revealed winners of its annual Strategic Patient Adherence Awards as part of its two-day conference about patient compliance with their drug regiments. This year’s award winners are: Best Integrated Program—Shire Pharmaceuticals: FOSRENOL ON TRACK Direct To Patient Support Program Best Disease State Program—BMS/Sanofi-Aventis Canada & […]
Posted in Events, Strategy | Also tagged , , , , , , , , | Leave a comment

AstraZeneca, BMS Announce Layoffs and Buyouts

AstraZeneca was the topic of conversation this week as word broke that the company is offering buyout deals to every member of its 5,500 US sales force. “AstraZeneca is making changes to our sales force, which will be managed first by looking at vacancies and offering field sales employees the opportunity to self-identify whether they […]
Posted in Strategy | Also tagged , , , , , , , | 1 Comment

Judge Throws The Book At Former Bristol-Myers Squibb Exec

Media wordsmiths are competing to outdo one another today in punny reporting on the news that ex-BMS exec Andrew Bodnar has been sentenced to write a book about the role he played in the firm’s 2006 reverse-payments case over generic Plavix. “Pen-ance: Bristol-Myers Exec Gets Two Years of Hard Writing,” The Wall Street Journal Law […]
Posted in Legal | Also tagged , , , , , , , | Leave a comment
  • Categories

  • Meta